SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study

Ritzmann, Timothy A; Chapman, Rebecca J; Kilday, John-Paul; Thorp, Nicola; Modena, Piergiorgio; Dineen, Robert A; Macarthur, Donald; Mallucci, Conor; Jaspan, Timothy; Pajtler, Kristian W; Giagnacovo, Marzia; Jacques, Thomas; Paine, Simon; Ellison, David; Bouffet, Eric; Grundy, Richard G

doi:10.1093/neuonc/noac012

All Outputs (1)

SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study (2022)
Journal Article
Ritzmann, T. A., Chapman, R. J., Kilday, J.-P., Thorp, N., Modena, P., Dineen, R. A., …Grundy, R. G. (2022). SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study. Neuro-Oncology, 24(6), 936–948. https://doi.org/10.1093/neuonc/noac012

Background
SIOP Ependymoma I was a non-randomised trial assessing event free and overall survival (EFS/OS) of non-metastatic intracranial ependymoma in children aged 3 to 21 years treated with a staged management strategy. A further aim was to asses... Read More about SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study.